» Articles » PMID: 34381279

Knowledge, Attitude, and Barriers Toward ADRs Reporting Among Health-Care Professionals at Tertiary Care Health Settings in Peshawar, Pakistan: A Web Based Study

Overview
Journal Hosp Pharm
Publisher Sage Publications
Date 2021 Aug 12
PMID 34381279
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Underreporting of adverse drug reactions (ADRs) is considered a major determinant of poor ADR signal detection in Pakistan. Considering this, the study was proposed to evaluate healthcare professionals' (HCPs) knowledge attitude toward and the barriers that discourse ADRs reporting. A cross-sectional survey was distributed among HCPs in 3 major tertiary care facilities of Peshawar. A self-administered, 31 items questionnaire was circulated online to collect the required information. Relative index ranking was used to identify the top barriers to the ADR reporting process. HCPs (n = 322) were requested, and over one-third (n = 122) responded. Of the total, 97 (79.5%) were males, and by designation, 59(48.4%) were resident medical officers. About 45% of the HCPs did not identify the appropriate pharmacovigilance (PV) definition. More than half of the HCPs (52.2%) distinguished the appropriate PV purpose. Nearly 80% HCPs did not know the acceptable reporting time frame, while 22.1% HCPs knew that regulatory body for ADRs does not exist in Pakistan. The majority (95.08%) of the HCPs either strongly agreed or agreed that reporting an ADRs is a professional obligation and all the HCPs were of the opinion that PV should be taught in detail to HCPs. Exploring the barriers, it was identified that the key barriers to ADRs reporting were "unavailability of professional environment to discuss ADRs," Relative Importance Index (RII) = 0.813, "lack of incentives for reporting" (RII = 0.774), "lack of knowledge regarding reporting" (RII = 0.693), and "insufficient knowledge of pharmacotherapy in detecting ADRs" (RII = 0.662). In addition to these, "complicated reporting forms" (RII = 0.616), "lack of motivation for reporting ADRs" (RII = 0.610), and "absence of professional confidence" were seen as major hindrances in effective reporting of ADRs (RII = 0.598). Concerning PV and ADR reporting poor knowledge was noted. However, the majority of the HCPs showed an explicit attitude regarding ADRs reporting. The majority of the HCPs disclosed unavailability of professional environment to discuss about ADRs, lack of incentives, and how to report the main factors hindering the ADRs reporting. It is emphasized that health authorities carve out a niche for a well purposeful PV center and pledge educational activities and trainings for increasing understanding and approaches regarding reporting of ADR.

Citing Articles

Improvement in Adverse Drug Reaction (ADR) Knowledge: A Pre- and Post-video Intervention Study Among Doctors.

Patel K, Patel S, Patel S, Patel D, Rana D, Shah V Cureus. 2024; 16(8):e67622.

PMID: 39314617 PMC: 11419404. DOI: 10.7759/cureus.67622.


Awareness, knowledge, attitude, and practice of adverse drug reaction reporting among health workers in primary health centres participating in seasonal malaria chemoprevention campaign in Nigeria in 2022: a cross-sectional survey.

Rotimi K, Fagbemi B, Omole G, Biambo A, Ibinaiye T, Iwegbu A BMC Health Serv Res. 2024; 24(1):952.

PMID: 39164692 PMC: 11337761. DOI: 10.1186/s12913-024-11343-y.


An Awareness of Pharmacovigilance Among Healthcare Professionals Due to an Underreporting of Adverse Drug Reactions Issue: A Systematic Review of the Current State, Obstacles, and Strategy.

Putri R, Ikawati Z, Rahmawati F, Yasin N Curr Drug Saf. 2024; 19(3):317-331.

PMID: 38989832 PMC: 11327747. DOI: 10.2174/0115748863276456231016062628.


Knowledge, attitude and practices about pharmacovigilance activities among hospital nurses: a multicentre cross-sectional survey.

Mahfodz M, Siddiqui S, Zainal H J Res Nurs. 2024; 29(3):259-274.

PMID: 38883248 PMC: 11179598. DOI: 10.1177/17449871241232340.


Evaluation of health care professionals' knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A cross-sectional multicentral study.

Khan Z, Karatas Y, Hamid S PLoS One. 2023; 18(5):e0285811.

PMID: 37224133 PMC: 10208525. DOI: 10.1371/journal.pone.0285811.


References
1.
Figueiras A, Herdeiro M, Polonia J, Gestal-Otero J . An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006; 296(9):1086-93. DOI: 10.1001/jama.296.9.1086. View

2.
Li Q, Zhang S, Chen H, Fang S, Yu X, Liu D . Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J (Engl). 2004; 117(6):856-61. View

3.
Abdel-Latif M, Abdel-Wahab B . Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia. Saudi Pharm J. 2015; 23(2):154-61. PMC: 4420988. DOI: 10.1016/j.jsps.2014.07.005. View

4.
Bisht M, Singh S, Dhasmana D . Effect of educational intervention on adverse drug reporting by physicians: a cross-sectional study. ISRN Pharmacol. 2014; 2014:259476. PMC: 3977536. DOI: 10.1155/2014/259476. View

5.
Gupta S, Nayak R, Shivaranjani R, Vidyarthi S . A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India. Perspect Clin Res. 2015; 6(1):45-52. PMC: 4314847. DOI: 10.4103/2229-3485.148816. View